Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain
暂无分享,去创建一个
J. Girault | E. Valjent | C. Pagès | J. Caboche | D. Hervé
[1] N. Volkow,et al. The neuroscience of addiction , 2005, Nature Neuroscience.
[2] B. Roques,et al. Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice , 2003, British journal of pharmacology.
[3] R. Polakiewicz,et al. Behavioral/systems/cognitive Brain Region-specific Mechanisms for Acute Morphine- Induced Mitogen-activated Protein Kinase Modulation and Distinct Patterns of Activation during Analgesic Tolerance and Locomotor Sensitization Opioid-receptor Activation in Cell Lines Results in Phosphorylation of P42/ , 2022 .
[4] P. Greengard,et al. Opposite regulation by typical and atypical anti‐psychotics of ERK1/2, CREB and Elk‐1 phosphorylation in mouse dorsal striatum , 2003, Journal of neurochemistry.
[5] J. Girault,et al. Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction. , 2003 .
[6] E. Nestler,et al. Regulation of CRE‐mediated transcription in mouse brain by amphetamine , 2003, Synapse.
[7] J. Girault,et al. Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus , 2003, The Journal of Neuroscience.
[8] P. Soubrié,et al. Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex , 2003, The European journal of neuroscience.
[9] D. David,et al. Antidepressant-like effects in various mice strains in the forced swimming test , 2003, Psychopharmacology.
[10] R. Malenka,et al. Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.
[11] I. McGregor,et al. Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain , 2003, Neuropharmacology.
[12] R. Wise. Brain Reward Circuitry Insights from Unsensed Incentives , 2002, Neuron.
[13] W. Schultz. Getting Formal with Dopamine and Reward , 2002, Neuron.
[14] L. Mao,et al. Amphetamine Increases Phosphorylation of Extracellular Signal-regulated Kinase and Transcription Factors in the Rat Striatum via Group I Metabotropic Glutamate Receptors , 2002, Neuropsychopharmacology.
[15] C. Brignell,et al. Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users , 2002, Psychopharmacology.
[16] John Q. Wang,et al. CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons , 2002, Neuroreport.
[17] John N. J. Reynolds,et al. Dopamine-dependent plasticity of corticostriatal synapses , 2002, Neural Networks.
[18] David P Wolfer,et al. Knockout of ERK1 MAP Kinase Enhances Synaptic Plasticity in the Striatum and Facilitates Striatal-Mediated Learning and Memory , 2002, Neuron.
[19] R. Maldonado,et al. Cannabinoid Addiction: Behavioral Models and Neural Correlates , 2002, The Journal of Neuroscience.
[20] Barry J. Everitt,et al. Psychomotor Stimulant Addiction: A Neural Systems Perspective , 2002, The Journal of Neuroscience.
[21] M. Barrot,et al. Regional and Cellular Mapping of cAMP Response Element-Mediated Transcription during Naltrexone-Precipitated Morphine Withdrawal , 2002, The Journal of Neuroscience.
[22] Mark J. Thomas,et al. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine , 2001, Nature Neuroscience.
[23] N. Jamshidi,et al. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.
[24] L. Vanderschuren,et al. A single exposure to morphine induces long‐lasting behavioural and neurochemical sensitization in rats , 2001, The European journal of neuroscience.
[25] S. Hyman,et al. Addiction and the brain: The neurobiology of compulsion and its persistence , 2001, Nature Reviews Neuroscience.
[26] J. Wickens,et al. A cellular mechanism of reward-related learning , 2001, Nature.
[27] D. Ji,et al. Synaptic Plasticity and Nicotine Addiction , 2001, Neuron.
[28] M. Besson,et al. Δ9‐tetrahydrocannabinol‐induced MAPK/ERK and Elk‐1 activation in vivo depends on dopaminergic transmission , 2001, The European journal of neuroscience.
[29] Mark A. Ungless,et al. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons , 2001, Nature.
[30] Eric J. Nestler,et al. Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.
[31] G. Koob,et al. Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.
[32] M. Besson,et al. Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties , 2000, The Journal of Neuroscience.
[33] M. Parmentier,et al. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice , 2000, The European journal of neuroscience.
[34] G. Di Chiara,et al. Stimulation of In Vivo Dopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs , 2000, The Journal of Neuroscience.
[35] A. Frazer. Norepinephrine involvement in antidepressant action. , 2000, The Journal of clinical psychiatry.
[36] Mark J. Thomas,et al. Modulation of Long-Term Depression by Dopamine in the Mesolimbic System , 2000, The Journal of Neuroscience.
[37] H. Mansvelder,et al. Long-Term Potentiation of Excitatory Inputs to Brain Reward Areas by Nicotine , 2000, Neuron.
[38] J. Kauer,et al. Amphetamine Blocks Long-Term Synaptic Depression in the Ventral Tegmental Area , 2000, The Journal of Neuroscience.
[39] Marc Parmentier,et al. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A2A receptors , 2000, British journal of pharmacology.
[40] S. Hyman,et al. Addiction, Dopamine, and the Molecular Mechanisms of Memory , 2000, Neuron.
[41] L. Vanderschuren,et al. A Single Exposure to Amphetamine Is Sufficient to Induce Long-Term Behavioral, Neuroendocrine, and Neurochemical Sensitization in Rats , 1999, The Journal of Neuroscience.
[42] S. File,et al. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety , 1999, The European journal of neuroscience.
[43] B. Prasad,et al. Neurotrophin-3 Contributes to the Initiation of Behavioral Sensitization to Cocaine by Activating the Ras/Mitogen-Activated Protein Kinase Signal Transduction Cascade , 1999, The Journal of Neuroscience.
[44] P. Blier,et al. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study , 1999, Psychopharmacology.
[45] E. Zvartau,et al. Caffeine place conditioning in rats: comparison with cocaine and ethanol , 1998, European Neuropsychopharmacology.
[46] D. A. King,et al. Cocaine and Caffeine Conditioned Place Preference, Locomotor Activity, and Additivity , 1998, Pharmacology Biochemistry and Behavior.
[47] B. Fredholm,et al. Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.
[48] V. Höllt,et al. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine‐dependent rats in vivo , 1998, The European journal of neuroscience.
[49] C. Nemeroff,et al. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.
[50] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[51] W. Schultz. Dopamine neurons and their role in reward mechanisms , 1997, Current Opinion in Neurobiology.
[52] A M Graybiel,et al. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] L. Angelis. Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[54] B. Costall,et al. Muscarinic antagonists are anxiogenic in rats tested in the black-white box , 1996, Pharmacology Biochemistry and Behavior.
[55] R. Malenka,et al. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens , 1994, Nature.
[56] H. Lublin,et al. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment , 1993, Psychopharmacology.
[57] J. Hietala,et al. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists. , 1993, European journal of pharmacology.
[58] H. Akil,et al. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1992, Neuroscience.
[59] H. Akil,et al. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1991, Neuroscience.
[60] M. Caron,et al. Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[61] Philip Seeman,et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.
[62] K. Mueller,et al. Scopolamine produces locomotor stereotypy in an open field but apomorphine does not , 1990, Pharmacology Biochemistry and Behavior.
[63] L. Heimer,et al. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata , 1988, Neuroscience.
[64] T. Chase,et al. The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand , 1988, Neuroscience.
[65] G. Di Chiara,et al. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[66] A. Uzan,et al. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic postsynaptic receptors , 1979, Neuropharmacology.
[67] I. McGregor,et al. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. , 2003, Neuropharmacology.
[68] E. Valjent,et al. Mitogen-activated protein kinase/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory? , 2001, Molecular neurobiology.
[69] E. Valjent,et al. A behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice , 2000, Psychopharmacology.
[70] E. Valjent,et al. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. , 2000, Psychopharmacology.
[71] B. Kieffer. Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.
[72] G. Di Chiara. Drug addiction as dopamine-dependent associative learning disorder. , 1999, European journal of pharmacology.
[73] S. Amara,et al. Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.
[74] L. Heimer,et al. Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.